NovaGen Group is an investigational longevity science and AI health intelligence company currently developing the Neo Prometheus Protocol.
NovaGen Group has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
NovaGen Group's investors include Genova Capital.
NovaGen Group is headquartered in Amsterdam, The Netherlands.
NovaGen Group is an investigational longevity science and AI health intelligence company currently developing the Neo Prometheus Protocol.
NovaGen Group is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NovaGen Group — Funding & Investors." VCBacked, September 14, 2026, https://www.vcbacked.co/company/novagen-group. Accessed October 1, 2026.
VCBacked. (2026). NovaGen Group — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/novagen-group
{{cite web |title=NovaGen Group — Funding & Investors |url=https://www.vcbacked.co/company/novagen-group |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated